Michael Burgess said...
To me, diseases like muscular dystrophy are why the expedited approval pathways are so important.
Context
Burgess advocates for expedited approval pathways for muscular dystrophy treatments.
05/19/2014
Burgess advocates for expedited approval pathways for muscular dystrophy treatments.
05/19/2014